Skip to content

Clinical effect of Midazolam oral liquid on preoperative anti anxiety/sedation in adults

Clinical effect of Midazolam oral liquid on preoperative anti anxiety/sedation in adults

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092380
Enrollment
Unknown
Registered
2024-11-14
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing general anesthesia surgery

Interventions

M1:Oral Midazolam oral solution 7.5mg
M2:Oral Midazolam oral solution 10mg
M3:Oral Midazolam oral solution 12.5mg
control group:Oral equidose placebo

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria (1) Age 18-65 years old; (2) Deviation from ideal body weight = 25%; (3) American Association of Anesthesiologists ASA I-II; (4) The operation duration is less than 2h (such as Appendectomy, induced abortion, hernia repair and other short operations); (5) No history of long-term use of analgesic, sedative and anti anxiety drugs in the past; (6) Informed consent, voluntarily participate in the experiment and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria (1) Patients with known Drug allergy to Midazolam or benzodiazepine, acute closed eye glaucoma or open angle glaucoma without effective treatment; (2) Weight exceeds ideal weight by ± 25%; (3) Patients with any serious systemic organ disease (heart lung/kidney/liver), Nervous system disease (cerebral palsy, autism, etc.), or combined use of Anesthetic or other central nervous system inhibitors; (4) Patients who have taken any drugs that may interfere with the pharmacokinetics or pharmacodynamics of Midazolam, such as Antifungal, Macrolide antibiotics, Cimetidine, rifamycin or Calcium channel blockers; (5) Patients with communication barriers, cognitive impairment, and a history of mental illness; (6) Pregnant women; (7) Subjects deemed unsuitable by the researchers for participation in this study.

Design outcomes

Primary

MeasureTime frame
Time for Ramsay Sedation Scale = 3;

Secondary

MeasureTime frame
Anxiety Visual Simulation Anxiety Level;Preoperative anxiety level in Amsterdam;Preoperative anxiety level;Ramsay Sedation Scale calmness level;Heart rate;blood oxygen saturation;blood pressure;Anesthetic usage;Satisfaction;Pre operative knowledge level in Amsterdam;

Countries

People's Republic of China

Contacts

Public ContactGuanghong Xu

The First Affiliated Hospital of Anhui Medical University

xuguanghong2004@163.com+86 138 5694 9535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026